AI & Biopharma
Google-Backed Isomorphic Raises $2.1 Billion for AI Drug Discovery
By Intent.Health Team • May 12, 2026
What’s happening
AI drug discovery company Isomorphic Labs raised $2.1 billion to expand its AI-driven pharmaceutical research platform.
The company is backed by:
- Google
- Alphabet’s DeepMind division
What’s changing / Business impact
- Massive investment flowing into: AI-driven drug discovery and pharmaceutical AI infrastructure.
- Drug development may become: faster, more data-driven, and more automated.
Why this matters
Traditional drug development takes many years, costs billions, and has high failure rates.
This shows:
- AI is becoming central to future pharmaceutical research.
- Tech companies are moving deeper into healthcare and biotech.